IT1270846B - Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. - Google Patents
Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.Info
- Publication number
- IT1270846B IT1270846B ITBO930205A ITBO930205A IT1270846B IT 1270846 B IT1270846 B IT 1270846B IT BO930205 A ITBO930205 A IT BO930205A IT BO930205 A ITBO930205 A IT BO930205A IT 1270846 B IT1270846 B IT 1270846B
- Authority
- IT
- Italy
- Prior art keywords
- sulodexide
- contain
- treatment
- diabetic nephropathy
- specialties
- Prior art date
Links
- GRYSXUXXBDSYRT-WOUKDFQISA-N (2r,3r,4r,5r)-2-(hydroxymethyl)-4-methoxy-5-[6-(methylamino)purin-9-yl]oxolan-3-ol Chemical compound C1=NC=2C(NC)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1OC GRYSXUXXBDSYRT-WOUKDFQISA-N 0.000 title abstract 3
- 229920000439 Sulodexide Polymers 0.000 title abstract 3
- 229960003491 sulodexide Drugs 0.000 title abstract 3
- 208000007342 Diabetic Nephropathies Diseases 0.000 title abstract 2
- 208000033679 diabetic kidney disease Diseases 0.000 title abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000004347 intestinal mucosa Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
L'oggetto della presente invenzione è costituito dall'uso di sulodexide, glicosaminoglicano di origine naturale estratto da mucosa intestinale di mammifero, e di specialità medicinali che lo contengono nel trattamento di pazienti affetti da nefropatia di origine diabetica.L'efficacia del sulodexide è stata dimostrata dalla significativa diminuzione dell'albumina in pazienti diabetici microalbuminurici trattati con composizioni farmaceutiche somministrate per via orale contenenti quantità terapeuticamente efficaci di farmaco;/
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBO930205A IT1270846B (it) | 1993-05-10 | 1993-05-10 | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. |
CA002120062A CA2120062C (en) | 1993-05-10 | 1994-03-28 | Use of sulodexide and of medicines containing it in the treatment of diabetic nephropathy |
US08/227,502 US5496807A (en) | 1993-05-10 | 1994-04-14 | Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it |
JP6091713A JP2702400B2 (ja) | 1993-05-10 | 1994-04-28 | 糖尿病性腎症治療用スロデキサイド含有医薬 |
KR1019940009102A KR0165567B1 (ko) | 1993-05-10 | 1994-04-28 | 술로덱사이드를 함유하는 당뇨성 신장병증 치료약 |
EP94107051A EP0624374B1 (en) | 1993-05-10 | 1994-05-05 | Use of sulodexide and of medicines containing it for the treatment of diabetic nephropathy |
AT94107051T ATE198278T1 (de) | 1993-05-10 | 1994-05-05 | Verwendung von sulodexid und von arzneimitteln, die dieses enthalten, zur behandlung der diabetischen nephropathie |
ES94107051T ES2152272T3 (es) | 1993-05-10 | 1994-05-05 | Uso de sulodexide y de medicamentos que lo contienen para el tratamiento de la nefropatia diabetica. |
DK94107051T DK0624374T3 (da) | 1993-05-10 | 1994-05-05 | Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati |
PT94107051T PT624374E (pt) | 1993-05-10 | 1994-05-05 | Utilizacao de sulodexida e de medicamentos que contem tal composto para o tratamento de nefropatia diabetica |
DE69426471T DE69426471T2 (de) | 1993-05-10 | 1994-05-05 | Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie |
GR20010400047T GR3035231T3 (en) | 1993-05-10 | 2001-01-11 | Use of sulodexide and of medicines containing it for the treatment of diabetic nephropathy. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBO930205A IT1270846B (it) | 1993-05-10 | 1993-05-10 | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITBO930205A0 ITBO930205A0 (it) | 1993-05-10 |
ITBO930205A1 ITBO930205A1 (it) | 1994-11-10 |
IT1270846B true IT1270846B (it) | 1997-05-13 |
Family
ID=11339016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITBO930205A IT1270846B (it) | 1993-05-10 | 1993-05-10 | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5496807A (it) |
EP (1) | EP0624374B1 (it) |
JP (1) | JP2702400B2 (it) |
KR (1) | KR0165567B1 (it) |
AT (1) | ATE198278T1 (it) |
CA (1) | CA2120062C (it) |
DE (1) | DE69426471T2 (it) |
DK (1) | DK0624374T3 (it) |
ES (1) | ES2152272T3 (it) |
GR (1) | GR3035231T3 (it) |
IT (1) | IT1270846B (it) |
PT (1) | PT624374E (it) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1274351B (it) * | 1994-10-06 | 1997-07-17 | Alfa Wassermann Spa | Uso di alcuni glicosaminoglicani nella dialisi peritoneale. |
IT1299969B1 (it) * | 1998-04-15 | 2000-04-04 | Alfa Wassermann Spa | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica. |
IL127896A0 (en) * | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
US7259152B2 (en) * | 2000-06-07 | 2007-08-21 | Alfa Wasserman, Inc. | Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
NZ530037A (en) * | 2001-06-12 | 2006-03-31 | Keryx Biopharmaceuticals Inc | Use of glycosaminoglycans for the treatment of HIV-associated nephropathy |
WO2006039709A1 (en) * | 2004-10-01 | 2006-04-13 | Keryx Biopharmaceuticals, Inc. | Methods using glycosaminoglycans for the treatment of kidney disease |
JP4705628B2 (ja) | 2005-02-03 | 2011-06-22 | 太陽化学株式会社 | 糖尿病および/または糖尿病性腎症の予防、改善、または治療用組成物 |
JP2008540448A (ja) * | 2005-05-05 | 2008-11-20 | ケリク ビオファルマセウチカルス インコーポレーテッド | 糖尿病性腎症の治療において、スロデキシド及び血圧低下薬を用いた併用療法 |
EP1968561B8 (en) * | 2005-12-22 | 2010-10-20 | Kiacta Sàrl | Treatment of diabetic nephropathy |
KR20090035581A (ko) * | 2006-08-04 | 2009-04-09 | 아지노모토 가부시키가이샤 | 신장 기능 장해 예방ㆍ치료제 |
WO2008070778A2 (en) * | 2006-12-06 | 2008-06-12 | Nephrogenex Inc. | Pyridoxamine and low molecular weight heparinoids for diabetic kidney disease |
AU2007337806A1 (en) * | 2006-12-22 | 2008-07-03 | Bellus Health (International) Limited | Methods, compounds, and compositions for treating metabolic disorders and diabetes |
CN101632686A (zh) * | 2008-04-04 | 2010-01-27 | 马斯特里赫特大学 | 糖胺聚糖用于修复糖萼的用途 |
DK2427416T3 (en) | 2009-05-04 | 2016-06-13 | Prometic Pharma Smt Ltd | Substituted aromatic compounds, and pharmaceutical uses thereof |
EP2632885B1 (en) | 2010-10-27 | 2018-01-03 | Prometic Pharma Smt Limited | Phenylketone carboxylate compounds and pharmaceutical uses thereof |
JP7357948B2 (ja) | 2018-07-13 | 2023-10-10 | ユニヴァーシティー オブ マイアミ | 腎臓障害を治療するための方法 |
US20200085810A1 (en) | 2018-07-26 | 2020-03-19 | Hoffmann-La Roche Inc. | Compounds for use in treating kidney disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1245761B (it) * | 1991-01-30 | 1994-10-14 | Alfa Wassermann Spa | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. |
IT1245907B (it) * | 1991-05-17 | 1994-10-25 | Alfa Wassermann Spa | Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica. |
-
1993
- 1993-05-10 IT ITBO930205A patent/IT1270846B/it active IP Right Grant
-
1994
- 1994-03-28 CA CA002120062A patent/CA2120062C/en not_active Expired - Lifetime
- 1994-04-14 US US08/227,502 patent/US5496807A/en not_active Expired - Lifetime
- 1994-04-28 JP JP6091713A patent/JP2702400B2/ja not_active Expired - Lifetime
- 1994-04-28 KR KR1019940009102A patent/KR0165567B1/ko not_active IP Right Cessation
- 1994-05-05 DK DK94107051T patent/DK0624374T3/da active
- 1994-05-05 EP EP94107051A patent/EP0624374B1/en not_active Expired - Lifetime
- 1994-05-05 AT AT94107051T patent/ATE198278T1/de active
- 1994-05-05 DE DE69426471T patent/DE69426471T2/de not_active Expired - Lifetime
- 1994-05-05 PT PT94107051T patent/PT624374E/pt unknown
- 1994-05-05 ES ES94107051T patent/ES2152272T3/es not_active Expired - Lifetime
-
2001
- 2001-01-11 GR GR20010400047T patent/GR3035231T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT624374E (pt) | 2001-04-30 |
ITBO930205A0 (it) | 1993-05-10 |
DE69426471D1 (de) | 2001-02-01 |
EP0624374B1 (en) | 2000-12-27 |
JPH06329541A (ja) | 1994-11-29 |
ITBO930205A1 (it) | 1994-11-10 |
CA2120062A1 (en) | 1994-11-11 |
DK0624374T3 (da) | 2001-01-29 |
CA2120062C (en) | 1999-05-25 |
JP2702400B2 (ja) | 1998-01-21 |
DE69426471T2 (de) | 2001-05-03 |
EP0624374A1 (en) | 1994-11-17 |
US5496807A (en) | 1996-03-05 |
ES2152272T3 (es) | 2001-02-01 |
ATE198278T1 (de) | 2001-01-15 |
GR3035231T3 (en) | 2001-04-30 |
KR0165567B1 (ko) | 1999-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1270846B (it) | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. | |
BR9909672A (pt) | uso de um composto medicinal ativo no preparo de um medicamento para o tratamento de hipertensão | |
BR0009016A (pt) | Composição de apomorfina e sildenafil | |
HUT60630A (en) | Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature | |
ATE282418T1 (de) | Orale verabreichung wirksamer mengen von hyaluronsäure | |
FI940787A0 (fi) | Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa | |
ES2109899T1 (es) | Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos. | |
BR9709838A (pt) | Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase | |
BR9814378A (pt) | Forma de dosagem de liberação prolongada farmacêutica revestida entérica de um inibidor de h+, k+-atpase, processos para a manufatura da mesma, para melhorar a inibição de secreção de ácido gástrico, para melhorar o efeito terapêutico no tratamento de distúrbios gastrointentinais, para receber um perfil de plasma prolongado de um inibidor da h+, k+-atpase, e, usos de uma composição farmacêutica e de inibidor da h+, k+-atpase | |
BR9608435A (pt) | Metodo para medicação do sistema de controle inflatório e de reações inflamatórias adversas e para produção de composto para o tratamento da patologia de reações inflamatórias adversas. | |
BR0116862A (pt) | Medicamento, métodos para tratar um paciente com osteonecrose e/ou osteocondrite dissecans, para prevenir a osteonecrose e/ou osteocondrite dissecans em um paciente em risco de cada uma das ditas doenças, uso de um medicamento, e, método para prevenir a destruição da cartilagem ou condrólise associadas com osteonecrose e/ou osteocondrite dissecans | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
BR0214075A (pt) | Dosagem unitária que compreende um análogo de prostaglandina para tratar constipação | |
ES2139842T3 (es) | Uso de la melatonina para tratar a pacientes que sufren drogodependencia. | |
BR0009380A (pt) | Tratamento de câncer melhorado comtemozolomida | |
JP2000512270A (ja) | 単純ヘルペスの処置のための組成物および方法 | |
BR9908716A (pt) | Tratamento de disfunção sexual em certos grupos de pacientes | |
EA200200801A1 (ru) | Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия | |
BR9907234A (pt) | Polìmeros ligantes de gordura | |
HUP0301831A2 (hu) | Gepiron bioaktív metabolitjainak alkalmazása pszichológiai rendellenességek kezelésére | |
BE1002256A3 (fr) | Medicaments. | |
HUP9901935A2 (hu) | Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet | |
DE3688787D1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
EE9900346A (et) | Viljatusevastane ja viljastumisvõimet tõstev ravim | |
MX9303985A (es) | Nucleosidos terapeuticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970423 |